第 1 到 30 筆結果,共 30 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective | TUNG-HUNG SU ; JIA-HORNG KAO | Clinical Liver Disease | 1 | 0 | |
2 | 2017 | Unmet Needs in Clinical and Basic Hepatitis B Virus Research | TUNG-HUNG SU ; JIA-HORNG KAO | Journal of Infectious Diseases | 19 | 17 | |
3 | 2022 | Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy | TUNG-HUNG SU ; SHIH-JER HSU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
4 | 2017 | Surveillance of hepatocellular carcinoma by magnetic resonance imaging with liver-specific contrast | TUNG-HUNG SU ; JIA-HORNG KAO | JAMA Oncology | 3 | 2 | |
5 | 2017 | Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients | TUNG-HUNG SU ; JIA-HORNG KAO | Liver International | 2 | 2 | |
6 | 2024 | Reply to “Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy” | Lin, Meng-Ju; TUNG-HUNG SU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
7 | 2016 | Reply | TUNG-HUNG SU ; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology (Baltimore, Md.) | 0 | 0 | |
8 | 2024 | Reply | SHANG-CHIN HUANG ; TUNG-HUNG SU ; JIA-HORNG KAO | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | |||
9 | 2022 | Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities | Hsu, Yao-Chun; Tseng, Cheng-Hao; TUNG-HUNG SU ; JIA-HORNG KAO ; Nguyen, Mindie H | Gut | 3 | 2 | |
10 | 2010 | The passage of a colonic cast | TUNG-HUNG SU ; JYH-MING LIOU ; HSIU-PO WANG | The Lancet | 6 | 6 | |
11 | 2016 | Multiple Giant Mushroom-like Tumors Inside the Stomach | Yeh C.-C.; MING YAO ; TUNG-HUNG SU | Gastroenterology | 2 | 1 | |
12 | 2014 | Molecular mechanism and treatment of viral hepatitis-related liver fibrosis | TUNG-HUNG SU ; JIA-HORNG KAO ; CHUN-JEN LIU | International Journal of Molecular Sciences | 57 | 52 | |
13 | 2020 | letter: hepatitis B virus infection and risk of multiple myeloma—a meta-analysis of cohort studies. Authors' reply | TUNG-HUNG SU ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 0 | 0 | |
14 | 2017 | letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D | Kao C.-N.; TUNG-HUNG SU ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 1 | 1 | |
15 | 2019 | letter to the Editor: Deliberations More Than a Cut-off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation | Jeng W.-J.; Hsu Y.-C.; TUNG-HUNG SU ; Chen C.-H. | Hepatology | 2 | 3 | |
16 | 2015 | Improving clinical outcomes of chronic hepatitis B virus infection | TUNG-HUNG SU ; JIA-HORNG KAO | Expert review of Gastroenterology and Hepatology | 26 | 23 | |
17 | 2020 | Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era | Chieh-Lung Cheng ; Huang, Sheng-Chuan; Chen, Jia-Hong; Wei, Chao-Hung; Fang, Wei-Quan; TUNG-HUNG SU ; CHANG-TSU YUAN ; JIA-HAU LIU ; MING-KAI CHUANG ; HWEI-FANG TIEN | The oncologist | 10 | 10 | |
18 | 2018 | HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed? | TUNG-HUNG SU ; TAI-CHUNG TSENG ; JIA-HORNG KAO | Hepatology | 11 | 10 | |
19 | 2023 | Halfway through HBV elimination - are we not waiting? | Wong, Grace Lai-Hung; Ong, Janus P; Kaewdech, Apichat; TUNG-HUNG SU | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | |||
20 | 2023 | Gamma-glutamyl transferase levels in the prediction of the outcomes of hepatocellular carcinoma after surgical resection | TUNG-HUNG SU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
21 | 2012 | Emerging hepatitis B virus infection in vaccinated populations: A rising concern? | TUNG-HUNG SU ; PEI-JER CHEN | Emerging Microbes and Infections | 13 | 10 | |
22 | 2023 | Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 0 | 0 | |
23 | 2024 | Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, Wei; Chang, Ting-Tsung; Yang, Hwai-I; Peng, Cheng-Yuan; Su, Chien-Wei; TUNG-HUNG SU ; Hu, Tsung-Hui; Yu, Ming-Lung; Yang, Hung-Chih; Wu, Jaw-Ching | Hepatology international | |||
24 | 2021 | Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients | Cheng, Huei-Ru; HUNG-CHIH YANG ; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Hepatology international | 0 | 0 | |
25 | 2017 | Combination therapy for chronic hepatitis B: Current updates and perspectives | TUNG-HUNG SU ; CHUN-JEN LIU | Gut and Liver | 19 | 15 | |
26 | 2020 | The clinical manifestations and management of COVID-19-related liver injury | TUNG-HUNG SU ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 31 | 25 | |
27 | 2007 | APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5] | TUNG-HUNG SU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 0 | 0 | |
28 | 2023 | Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B | Huang, Chiuan-Bo; TUNG-HUNG SU ; JIA-HORNG KAO | Liver international : official journal of the International Association for the Study of the Liver | 1 | 1 | |
29 | 2018 | Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma | Kuo Y.-C.; Shih S.-C.; Yu L.-Y.; MING-SHIANG WU ; TUNG-HUNG SU ; CHUN-JEN LIU ; Hu K.-C. | Helicobacter | 1 | 0 | |
30 | 2008 | Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection | TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 0 | 0 |